Background
As the only curative treatment for end-stage liver diseases, liver transplantation has been widely carried out around the world. But in the East Asian countries, due to the influence of traditional values and social customs, people are generally reluctant to donate their organs after death, resulting in an increasing gap between available organs and patients in the waiting list. Especially in China, where brain death has not been enacted, relatively poor quality grafts from cardiac death donors have greatly limited the promotion of donation after cardiac death (DCD) liver transplantation. In this background, living donor liver transplantation (LDLT) has been developing rapidly and achieved satisfactory long-term survival of both graft and recipient, with its unique advantages such as short waiting time, elective surgery, high graft quality and low incidence of immune rejection. However, most previous researches focused on the recipient, while donor safety as the first priority has not been fully described and investigated. Since performed the first adult-adult LDLT (A-ALDLT) in mainland China in 2002 [1] , our center has completed 356 cases of A-ALDLT. Recent years, we made some efforts to improve donor safety in LDLT, and this research is aimed to test the effect of these measures by retrospectively analyzing the postoperative complications in all 356 donors.
Material and Methods
The postoperative complications of 356 A-ALDLT donors in our center from January 2002 to September 2015 were retrospectively analyzed. This study was approved by the Regional Ethics Committee of our hospital, and due to its retrospective nature, informed consent was waived. These patients were divided into the pre-2008 group (before January 2008) and the post-2008 group (after January 2008), which marks the first and second half of our 15 years of LDLT experience, respectively. All postoperative complications were graded by the ClavienDindo classification [2] and compared between the 2 groups.
Donor selection
All donations are completely voluntary and approved by the ethical review. Potential donors aging from 18 to 60 years old were considered. The donor selection process includes health screening, blood tests, virological examination, imaging examination and psychological assessment. The inclusion and exclusion criteria were reported previously [3] .
Preoperative assessment
The donor's total liver volume was calculated by the West China formula we proposed [4] . We also developed our own formula to carry out noninvasive assessment on the degree of hepatic steatosis and avoided pre-donation liver biopsy [4] . Moderate macrovesicular steatosis (30~60% steatosis) was acceptable, but severe macrovesicular steatosis (>60% steatosis) was a contraindication for donation. Three-dimensional spiral enhanced CT was routinely used to check the hepatic artery, hepatic vein and portal vein for variations. MRI was done to define the biliary anatomy. If necessary, intraoperative cholangiogram was performed. Once the operation decision was made, three-dimensional print liver model was made to accurately calculate the total liver volume and the planned remnant liver volume [5] . Whenever possible, the remnant liver volume was maintained at above 40% to ensure donor safety. With the 3D model, the liver surgery was performed based on the intrahepatic duct structures to achieve precise anatomical liver resection.
Living donor hepatectomy
In most cases, we used the right lobe graft without the middle hepatic vein (MHV). Intraoperative ultrasound was used to define the MHV. Without vascular occlusion, the hepatic parenchyma was transected with a Cavitron Ultra-Sonic Aspirator (CUSA) and the MHV was retained to the donor. Laparoscopicassisted right lobe donor hepatectomy has been a routine practice in our center since 2011 [6] , which changed the traditional 20cm right subcostal incision to a 10cm median incision. Postoperatively, donors were sent to ICU for monitoring and treatment until they are stable enough to return to the ordinary ward.
Statistical methods
Continuous variables were expressed as medians with standard deviations (SD), and t test was used for comparison between groups. Categorical data were expressed as ratios and compared using the chi squared test. SPSS version 17.0 was used for all data management and statistical analyses. P<0.05 was considered statistically significant. Specific complications of the donors are shown in Table 3 . Biliary complications, including bile leakage and biliary stricture, were the most common complications, with an incidence of 8.4%. The second most common complication was infection, with an incidence of 7.0%, in which wound infection (3.4%) and abdominal infection (3.1%) accounted for the majority. Postoperative hemorrhage (2.2%) and pleural effusion (3.7%) were rare. Only 1 patient (0.3%) had portal vein thrombosis postoperatively, and was cured by thrombectomy.
Results

There
It is worth mentioning that in a previous study, in order to investigate the relationship between remnant liver volume (RLV) and complication rate, we collected and analyzed the data of 151 LDLT donors from 2002 to 2009. They were classified according to the RLV as the <35% group, 35~40% group, and >40% group. As shown in Table 4 , the incidence of severe complications (Clavien III) of the <35% group, 35~40% group, and >40% group was 21%, 15% and 6%, respectively, with statistically significant differences [3] .
Discussion
As an important means to address the worldwide shortage of liver grafts, A-ALDLT is the most serious operation a healthy person could undergo, so donor safety is the absolute priority. The first adult-child LDLT was performed in 1988 [7] , but it was not until 2000 that A-ALDLT was widely performed in Europe and the United States due to concerns over donor safety.
Most A-ALDLTs use the right liver lobe as the graft, which accounts for 50~70% of the donor liver volume. Because of the large volume of liver donated and the difficulty of surgery, donor safety in A-ALDLT has raised serious concerns [8, 9] . There are currently at least 19 donors who died of postoperative complications worldwide; most are right lobe donors, with a rough estimate of donor mortality at 0.2~0.5% [10] . In addition, 1 donor entered a vegetative state and 3 donors had to receive liver transplantations themselves [10] . Lo et al. [11] investigated 1508 donors from 5 liver transplantation centers in Asia and reported that the complication rate for right lobe donors was 28%. Previous reports ranged from 0% to 67% [12] [13] [14] [15] . This diversity in complication rates may be due to the difference in definitions and criteria for postoperative complications in different centers, as well as in graft types and follow-up periods. In view of this, we carried out this investigation of donor complications in our own center to evaluate donor safety and test the effect of the measures we have taken to improve it.
In our study, the overall complication rate of LDLT donors was 23.0% (82/356). More than half of the complications were Clavien I (51.2%), suggesting that most complications were minor and controllable. In all the donors, the incidence of Clavien I, II, III, and IV complications was 11.8% (42/356), 5.9% (21/356), 5.1% (18/356), and 0.3% (1/356), respectively. Patel et al. [16] investigated 433 LDLT donors in 13 liver transplantation centers in the United States and reported the incidence of Clavien I, II, and III complications was 13.4%, 6%, and 2%, respectively, which is comparable to our results. In our study, the most common complication was biliary (8.4%), mostly bile leakage from the hepatic surface. That was different from the study of Ghobrial et al. [17] , in which infection was the most common complication, with an incidence of 12%. 
(1) West China formula for standard liver volume
In the donor selection and preoperative assessment process, it is crucial to accurately estimate the donor's standard liver volume (SLV). Generally, a thin-slice CT scan is used for this task, but its error rate was reported to be 5~25% [19] ; therefore, we thought it would be of great help to develop a formula for live size calculation.
We carried out a study on 115 LDLT donors in which the weight and volume of their right lobe grafts were measured on the back Abdominal infection 4 (3.1)
Pleural effusion 2 (1.6) 2 (0.9) 4 (1.1) determine the liver graft volume, then the data were compared with liver volumes calculated by CT preoperatively. Our statistical analysis led us to develop our West China formula: SLV (mL) =11.5×BW (body weight, kg)+334. Afterwards, we applied this formula to more than 200 LDLTs and achieved satisfactory results [3] . According to our experience, the West China formula has advantages over CT in both accuracy and convenience. It has also been adopted by other liver transplantation centers in China.
(2) RLV >40%
Remnant liver volume is a key factor affecting donor recovery and safety [20] . An appropriate RLV must meet recipient need and ensure donor safety at the same time. There is still controversy as to the optimal RLV. Some scholars suggested that an RLV of 30% is sufficient for donors, but others prefer to keep RLV >35% or even >40% [21] . A recent study by Kentaro et al. [22] found that larger partial resection (³35% of the original liver volume) may impair postsurgical asialoglycoprotein receptor (ASGPR) function, while smaller resection (<35%) was proved to be under the safety margin of hepatectomy. They suggested that careful attention must be paid to LDLT donors undergoing larger (³35%) partial resection. In A-ALDLT, we routinely use the right lobe without MHV as the graft so that the donors are safer with a relatively large RLV.
To solve the optimal RLV problem, in 2009 we performed a retrospective study on 151 LDLT donors who were classified according to the RLV. As displayed in Table 4 , the incidence rates of severe complications (Clavien III) of the 3 groups were significantly different [3] . Based on this result, we try to maintain a minimum RLV of 40% whenever possible.
(3) Noninvasive assessment of hepatic steatosis
Hepatic steatosis is a common risk factor for graft quality and donor safety. Severe macrovesicular steatosis (>60% steatosis) has a strong correlation with primary non-function (PNF), while moderate macrovesicular steatosis (30~60% steatosis) leads to damage in liver function and regeneration [23] . A recent study identified hepatic steatosis as an independent donor-associated risk factor of post-reperfusion severe hyperglycemia (PRSH) in patients undergoing LDLT [24] . Therefore, preoperative evaluation of hepatic steatosis is essential. Liver biopsy is the criterion standard, but is associated with a 1% rate of hemorrhage and 0.01% mortality [25] . Thus, we attempted to build a model to quantitatively predict the extent of hepatic macrovesicular steatosis (HMS) from data obtained noninvasively and thus avoid unnecessary liver biopsies. (5) Laparoscopic-assisted right hepatectomy in donors
Having been shown to not only reduce hospital stay, but also effectively reduce surgical complications, enhanced recovery after surgery (ERAS) protocols have been implemented extensively in gastrointestinal surgery and are now established as standard of care [26] . Recent years have witnessed increasing interest in application of enhanced recovery care programs in liver surgery [27] , especially after 2 RCTs demonstrated that overall morbidity was reduced following liver resection managed with fast-track surgery principles compared to conventional practice [28, 29] .
Minimally-invasive procedures are among the most important contributors to fast-track surgery. First introduced by Koffron et al. [30] in 2006, laparoscopic-assisted right hepatectomy has displayed remarkable advantages over the conventional open procedure by changing the traditional 20-cm right subcostal incision to a 10-cm upper median incision. According to a study by Imamura et al. [31] , living donor hepatectomy with an upper median incision is a preferable procedure in terms of physical status and safety. Our center was the first to apply this minimally-invasive procedure to living liver donors in China [6] . We also discovered that donors who received laparoscopic-assisted surgery had significantly less pain and achieved early expectoration, mobilization, and enteral nutrition postoperatively. Based on the theory of ERAS [32] , these would result in significant reduction of postoperative complications. Uncomplicated recovery reduced morbidity, hospital stay, and costs. In addition, even willingness to donate was encouraged due to the good cosmetic effects.
